v3.26.1
Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Disaggregation of Revenue [Line Items]        
Total product revenue, net $ 256,147 $ 194,430 $ 421,050 $ 351,644
Hypercortisolism Products        
Disaggregation of Revenue [Line Items]        
Total product revenue, net 208,583 194,430 373,486 351,644
Lifyorli        
Disaggregation of Revenue [Line Items]        
Total product revenue, net $ 47,564 $ 0 $ 47,564 $ 0